Welcome to the Boehringer Ingelheim Pharmaceuticals Inc.(BIPI)
and Lilly USA, LLC (Lilly) Alliance
on-line application and grant
management portal.
On January 11, 2011 BIPI and Lilly announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance.
By agreement between BIPI and Lilly, grant requests will be processed through the BIPI on-line grant system but the application request will be reviewed by both companies. Please review the following prior to submitting a request through our on-line system.
Medical Education Grants
A BIPI/Lilly medical education grant is designed to support independent medical education for healthcare providers and patients that may translate to better management of disease and improvement in patient safety and population health.
Please see below for submission timelines:
- Grant applications must be submitted no less than 60 days prior to the program start date.
New and Returning Visitors to BIPI/Lilly Medical Grants
To begin a new application, return to a saved application, or track the status of an application already submitted login at https://funding.boehringer-ingelheim.com/welcome/US/. If this is the first time you are visiting the site, you must register as a New User. An application ID beginning with "US IME", will be assigned once you submit the application.
2024 Educational Objectives - Cardiometabolism
For patients with heart failure or chronic kidney disease, improve clinicians’ ability to:
- Identify and diagnose patients early in disease progression
- Understand current clinical practice guidelines and new therapy options when
treating patients with heart failure (full spectrum of ejection fraction) and/or chronic
kidney disease (diabetic and non-diabetic)
Implementation of demonstrated evidence-based care best practices across care settings, including multi-disciplinary care and approaches to reducing barriers in managing patients with cardio-renal-metabolic comorbidities (i.e., type 2 diabetes, heart failure, and chronic kidney disease).
Responding to a Request for Proposal (RFP)
Throughout the year, the Medical Grants department may announce a Request for Proposal (RFP). The intent of this announcement is to notify experienced and accredited Continuing Medical Education (CME) providers and accredited Continuing Education (CE) providers that BIPI/Lilly is interested in receiving applications for educational grants for support consideration.
Grant application
welcome/US/. While RFPs may specify timing of requested responses, BIPI and Lilly will continue to review all grant requests which are received.
